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Abstract:  37 
 38 
Background: Alcohol-related disorders are common, expensive in their course and 39 
often underdiagnosed. To facilitate early diagnosis and therapy of alcohol-related 40 
disorders and to prevent later complications, questionnaires and biomarkers are 41 
useful.  42 
Methods: Indirect state markers like gamma-glutamyl-transpeptidase (GGT), mean 43 
corpuscular volume (MCV) and carbohydrate deficient transferrin (CDT) are 44 
influenced by age, gender, various substances and non-alcohol-related illnesses, and 45 
do not cover the entire timeline for alcohol consumption. Ethanol metabolites, such 46 
as ethyl glucuronide (EtG), ethyl sulphate (EtS), phosphatidylethanol (PEth) and fatty 47 
acid ethyl esters (FAEEs) have gained enormous interest in the last decades as they 48 
are detectable after ethanol intake.  49 
Results: For each biomarker, pharmacological characteristics, detection methods in 50 
different body tissues, sensitivity/specificity values, cut-off values, time frames of 51 
detection and general limitations are presented. Another focus of the review is the 52 
use of the markers in special clinical and forensic samples.  53 
Conclusion: Depending on the biological material used for analysis, ethanol 54 
metabolites can be applied in different settings such as assessment of alcohol intake, 55 
screening, prevention, diagnosis and therapy of alcohol use disorders. 56 
 57 
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Alcohol use disorders (AUD) cause approximately 4 % of deaths worldwide – more 65 
than HIV, violence, or tuberculosis. In general hospitals, up to 20 % of all inpatients 66 
have an alcohol use disorder. In surgical departments rates from 16 % to 35 % were 67 
described in patients with multiple trauma (Tonnesen & Kehlet, 1999; Spies et al., 68 
2001) leading to a number of unwanted consequences, including prolonged 69 
hospitalisation  (Tonnesen & Kehlet, 1999; Spies et al., 2001; Rubinsky et al., 2012), 70 
more time in Intensive Care Units and higher rates of complications (Rubinsky et al., 71 
2012).  72 
Of all alcohol-dependent individuals, 80 % are treated by general practitioners, 34 % 73 
in general hospitals and a low percentage by addiction specialists (Mann, 2002). 74 
To facilitate early diagnosis and therapy of alcohol-related disorders and thus prevent 75 
secondary complications, questionnaires like the Alcohol Use Disorders Identification 76 
Test (AUDIT) (Saunders et al., 1993) as well as reliable and valid biomarkers are 77 
useful. Biomarkers have the advantage to indicate and reflect alcohol intake, 78 
independent of recall bias of the interviewed subjects. 79 
Both indirect and direct state markers are routinely used to detect alcohol intake. The 80 
indirect state markers such as gamma-glutamyl-transpeptidase (GGT), mean 81 
corpuscular volume (MCV), and carbohydrate deficient transferrin (CDT) are 82 
influenced by a number of factors like  age, gender, and non-alcohol-related 83 
illnesses, and do not cover the entire time frame (acute, short-term, long-term) of 84 
alcohol use (Conigrave et al., 2002; Laposata, 1999; Helander, 2003; Hannuksela et 85 
al., 2007; Niemelä, 2007). 86 
Direct ethanol metabolites have gained interest in recent decades as they are 87 
biomarkers with high sensitivity and specificity.  Most frequently, EtG (ethyl 88 
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glucuronide) and PEth (phosphatidylethanol) are used in various settings and will 89 
therefore be discussed in more detail.   90 
 91 
Ethanol metabolites  92 
Ethanol metabolites are formed after alcohol consumption and are minor pathways of 93 
ethanol elimination. They each cover different time frames of detection and can be 94 
determined in different matrices.  95 
Routinely measured ethanol metabolites include: 96 
 Ethyl glucuronide (EtG) in serum, whole blood, urine and hair  97 
 Ethyl sulphate (EtS) in serum, whole blood and urine 98 
 Phosphatidylethanol (PEth) in whole blood   99 
 Fatty acid ethyl esters (FAEEs) especially in hair  100 
 101 
Generally, ethanol metabolites are detectable in serum or whole blood for hours 102 
(EtG, EtS), in urine for up to seven days (EtG, EtS), in whole blood over two weeks 103 
(PEth) and in hair over months (EtG, FAEEs) (review by Thon et al 2014). 104 
 105 
Ethyl glucuronide (EtG):  106 
A. Pharmacology  107 
Ethyl glucuronide (EtG) is a phase II metabolite of ethanol, has a molecular weight of 108 
222 g/mol and is is formed by the action of UDP-glucuronosyl transferase (Foti & 109 
Fisher, 2005). The possible effect of nutritional components such as flavonoids on 110 
EtG formation is currently under investigation and seems to be a possible partial 111 
explanation of the variability of EtG formation in humans (Schwab & Skopp, 2014).  112 
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Whereas the elimination of ethanol via glucuronidation is a minor pathway of alcohol 113 
metabolism (less than 0.1 %) EtG is a valuable biomarker of ethanol intake. EtG is 114 
non-volatile, water-soluble, and stable in storage. Depending on the amount of 115 
consumed alcohol and time spent for consumption, EtG is still detectable in the body 116 
long after completion of alcohol elimination (Schmitt et al., 1995, Wurst et al., 1999a, 117 
2004; Dahl et al., 2002, 2011a; Borucki et al., 2005, Halter et al. 2008).  118 
 119 
B. Specific body tissues, time frame and cut-off values  120 
Based on a literature review, Walsham and Sherwood (2012) sum up that EtG can be 121 
detected for up to 90 hours in urine. There is no difference regarding the elimination 122 
rate between a healthy population and heavy alcohol consumers at the beginning of 123 
detoxification treatment (Hoiseth et al., 2009).  124 
EtG is also detectable in post-mortem body fluids and tissues like gluteal and 125 
abdominal fat, liver, brain and cerebrospinal fluid (Wurst et al., 1999b), in bone 126 
marrow, muscle tissue (Schlögel et al., 2005) and finger nails (Berger et al., 2013). 127 
Even intake of small amounts of alcohol like 0.1 L champagne can be detected via 128 
EtG for up to 27 hours. Experiments with 1 g ethanol (champagne, whisky) (Thierauf 129 
et al., 2009) as well as use of mouthwash (Costantino et al., 2006)  and hand 130 
sanitizer gels (Rohrig et al., 2006) yielded ethyl glucuronide concentrations of less 131 
than 1.0 mg/L in urine. Measurable concentrations in urine were found for up to 11 132 
hours. This aspect is of relevance regarding unintentional exposure of alcohol: 133 
pralines, non-alcoholic beer, pharmaceutical products, fruit juice, sauerkraut, 134 
mouthwash products and hand sanitizer gels may contain small amounts of alcohol.  135 
Even the intake of 21 - 42 g yeast with approximately 50 g sugar leads to 136 
measureable EtG and EtS concentrations in urine (Thierauf et al., 2010). 137 
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Inhalation of ethanol vapors may be another source for EtG in urine. Arndt et al., 138 
(2014a) emphasize that ethanol is mainly incorporated by inhalation not via the skin 139 
by using hand sanitizers by hospital employees.  140 
Therefore, a patients’ claim not having consumed alcohol may be the truth even 141 
when EtG is detectable in urine. Since patients in withdrawal treatment should avoid 142 
even the smallest amount of alcohol, they have to be informed of such hidden 143 
sources of ethanol to avoid unintentional alcohol intake. A differential cut-off of 0.1 144 
mg/L in cases where total abstinence is the goal, and 1.0 mg/L if small amounts of 145 
alcohol intake are tolerated, have been recommended for practical reasons 146 
(Costantino et al., 2006; SAMHSA 2012) . 147 
Based on the fact that  exposure studies (by inhalation or disinfecting hands etc.) in 148 
humans never yielded results above 1.0 mg/L, a differential cut-off has been 149 
suggested (Thierauf et al., 2009; SAMHSA 2012):  150 
a) of 0.1 mg/L in cases where total abstinence is the goal 151 
b) of 1.0 mg/L or more for EtG to confirm drinking.  152 
c) In addition, a recent revision of the SAMHSA advisory suggests that values 153 
between 0.5 mg/L and 1.0 mg/L could be from previous drinking as well as 154 
from recent intense extraneous exposure within 24 hours or less. 155 
For further details, see table 1.  156 
 157 
Due to head hair growth of 1 cm per month, hair analysis allows a cumulative and 158 
retrospective assessment of ethanol intake for a longer time period as compared to 159 
blood and urine. In hair, hydrophilic EtG is incorporated through perspiration and/or 160 
from blood (Pragst & Yegles, 2007; Schräder et al 2012).  161 
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For the assessment of chronic excessive alcohol consumption, EtG and FAEEs can 162 
be used alone or in combination to increase the validity of hair analysis (Pragst & 163 
Yegles, 2008). 164 
According to the consensus of the Society of Hair Testing (SOHT, 2014), a 165 
concentration over 30 pg/mg EtG in the 0 - 3 cm up to 0 - 6 cm proximal scalp hair 166 
segment strongly suggests chronic excessive alcohol consumption.  167 
For abstinence assessment HEtG should be the first choice, according to both the 168 
consensus statement of the SOHT (2014) and a systematic review (Boscolo-Berto et 169 
al., 2014). A concentration below 7 pg/mg does not contradict self-reported 170 
abstinence of a person during the corresponding time period before sampling. A 171 
HEtG concentration above 7 pg/mg in the 0 - 3 cm up to 0 - 6 cm proximal scalp hair 172 
segment strongly suggests repeated alcohol consumption.  173 
In an alcohol drinking experiment, 32 women, who consumed 16 g alcohol per day, 174 
had EtG values of less than 7 pg in their scalp hair (Kronstrand et al., 2012). These 175 
divergent results may be explained by the fact that EtG values lower than 7 pg/mg do 176 
not exclude alcohol ingestion. Furthermore, scalp hair was cut pre-analytically in this 177 
study while previous studies pulverised the specimen: The pre-analytical preparation, 178 
such as washing, powdering (by a ball-mill) – or cutting by scissors in small pieces, 179 
extraction by solvents with or without ultrasonication, has been reported to influence 180 
the results significantly (Albermann et al., 2012a; Kummer et al., 2015; Mönch et al., 181 
2013). These factors need some standardization, otherwise – as seen in proficiency 182 
tests or other inter-laboratory tests, the precision of analysis is decreased. 183 
 184 
C. Methodical aspects  185 
A DRI® ethyl glucuronide enzyme immunoassay (DRI®-EtG EIA) is commercially 186 
available. The first study showed satisfying but not convincing results (Böttcher et al., 187 
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2008). Therefore, enquiries with medico-legal relevance need further confirmation 188 
with forensic-toxicologically acceptable methods like liquid chromatography – tandem 189 
mass spectrometry (LC-MS/MS (Weinmann et al., 2004).  190 
 191 
D. Limitations 192 
In recent years, the potential in vitro formation and degradation of EtG and EtS have 193 
gained attention (Helander et al., 2005; 2009; Baranowski et al., 2008; Halter et al., 194 
2009). Initially, hydrolysis of EtG caused by microbes in urinary tract infections, 195 
especially E.coli, was reported (Helander et al., 2005). Baranowski et al (2008) 196 
confirmed complete degradation of EtG within 3 to 4 days by E.coli and C. sordellii. In 197 
contrast, the stability of EtS for up to 11 days was shown (Baranowski et al., 2008).  198 
Furthermore, Hernandez Redondo et al. (2013) reported that the bacterial 199 
degradation of EtG by E. coli can be prevented by use of dried urine on filter paper.  200 
The WHO/ISBRA Study showed that EtG urine concentrations are influenced by age, 201 
gender, cannabis consumption and renal function. In contrast, race, nicotine 202 
consumption, body mass index, liver cirrhosis and body water content had no 203 
significant influence on EtG concentrations (Wurst et al., 2004a). The results 204 
concerning renal and liver functions have recently been confirmed by two studies, 205 
one in which EtG elimination was prolonged for 14 patients with reduced renal 206 
function (Hoiseth et al., 2013), and another study in which severity of liver disease 207 
had no influence on the validity of EtG as a marker of alcohol use (Stewart et al 208 
2013).  209 
The positive predictive values of EtG for patients, who claimed abstinence in the last 210 
3 days, were 81 %. The negative predictive values were 91 %. Had the patients 211 
claimed abstinence in the last 7 days, the positive predictive values would be 97 %, 212 
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the negative predictive values would be 85 % (Stewart et al., 2013, see also table 2a 213 
and b).  214 
Only single cases of false positive results for EtG in hair were found after use of EtG 215 
containing herbal lotions (Sporkert et al., 2012; Arndt et al., 2013).  Impaired kidney 216 
function may lead to higher HEtG levels, as preliminary results indicate (Hoiseth et al. 217 
2013).  218 
The concentration of EtG in hair can be influenced by cosmetic treatments and 219 
thermal hair straightening tools (Ettlinger et al., 2014).  Bleaching, perming and dying 220 
of hair may lead to lower concentrations of EtG or false-negative results (Yegles et 221 
al., 2004; Kerekes & Yegles, 2013; Morini et al., 2010a; Agius, 2014; Suesse et al., 222 
2012). 223 
The type of cosmetic hair treatment should be documented during sampling and 224 
considered during interpretation. EtG appears not to be influenced by ethanol-225 
containing hair care products, whereas their use may lead to false positive FAEEs 226 
(Hartwig et al., 2013; Suesse et al., 2012; Gareri et al., 2011). 227 
In contrast to hair analysis for drugs and medication, hair colour and melanin content 228 
in hair have no influence on HEtG (Kulaga et al., 2009; Appenzeller et al., 2007a). 229 
Also for gender no effect on HEtG concentration have been reported (Crunelle et al., 230 
2014a). In segmental investigations of hair samples, a chronological correlation to 231 
drinking or abstinent phases was reported for HEtG by two studies (Wurst et al., 232 
2008c; Appenzeller et al., 2007b), however not for FAEEs (Auwärter et al., 2004). 233 
Only for HEtG a correlation was found in 3 studies between the EtG content in hair 234 
and the amount of EtOH consumed (Appenzeller et al., 2007b; Crunelle et al., 2014b; 235 
Politi et al., 2006). Altogether, hair analysis is a useful tool to estimate overall ethanol 236 
intake over a longer time. 237 
    238 
10 
 
Ethyl sulphate (EtS) 239 
A. Pharmacology  240 
Ethyl sulphate (EtS) has a molecular weight of 126 g/mol, and represents, like EtG, a 241 
secondary elimination pathway for alcohol. EtS is detectable in varying inter-242 
individual concentrations (Dresen et al., 2004; Helander and Beck, 2004; Wurst et al., 243 
2006, Halter et al., 2008). An immunochemical detection test is currently not 244 
commercially available for EtS. For combined detection of EtS and EtG, use of rapid 245 
LC-MS/MS procedures is routinely applied.   246 
EtS formation is catalyzed by the enzyme sulpho-transferase and the breakdown by 247 
sulphatases.  248 
 249 
B. Specific body tissues, time frame and cut-off values 250 
EtS is detectable in the same body tissues as EtG. A cut-off of 0.05 mg/L for 251 
repeated alcohol intake was suggested (Albermann et al., 2012b). As for ethyl 252 
glucuronide, there is evidence of prolonged elimination in reduced renal function 253 
(Hoiseth et al., 2013). 254 
 255 
C. Methodical aspects  256 
Schneider and Glatt (2004) developed a liquid chromatography-tandem-mass 257 
spectrometry method with 2-propylsulphates as internal standard. Helander and Beck 258 
(2004) used liquid chromatography-electro spray-ionisation-mass spectrometry (LC-259 
ESI-MS) in a single-quadruple-modus and D5-ethyl sulfate as internal standard for the 260 
quantification of EtS in urine samples. The disadvantage of this method is a longer 261 
period of chromatographic separation. Furthermore, the exclusive monitoring of de-262 
protonated molecules in a single-MS does not meet forensic standards (Aderjan et 263 
al., 2000; SOFT/AAFS, 2006). At any rate, an additional fragment ion would be 264 
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required for the verification analyses according to forensic guidelines (SOFT/AAFS, 265 
2006). Even when this requirement from forensic guidelines does not need to be met 266 
in clinical diagnostics, it is still in demand in workplace drug testing in the USA. In this 267 
context, a LC-MS/MS method with penta-deuterium EtS as internal standard and two 268 
ion transitions (Dresen et al., 2004) raises particular interest, and can be used in 269 
forensic and medico-legal cases as well as in clinical routine (Skipper et al., 2004).  270 
 271 
D. Limitations:  272 
In contrast to the above-described potential of in vitro formation and degradation of 273 
EtG caused by microbes, Baranowski et al. showed the stability of EtS for up to 11 274 
days (Baranowski et al., 2008). Further studies with standardized test procedures for 275 
biodegradation showed that EtS in closed bottle test (OECD 301 D) remained stable 276 
for even longer periods whereas in the context of a higher bacterial density such as in 277 
the Manometric Respiratory Test (MRT) a reduction after 6 days was detected (Halter 278 
et al., 2009). This problem could be countered by cooling and the addition of 279 
stabilizers. 280 
The positive predictive value of EtS for patients, who claimed abstinence in the last 3 281 
days, was 70 %. The negative predictive values were 93 %. Had the patients claimed 282 
abstinence in the last 7 days, the positive predictive values would be 80 % 283 
respectively, the negative predictive values would be 85 % (Stewart et al., 2013, see 284 
also table 2a and b). 285 
 286 
Fatty acid ethyl esters (FAEEs)  287 
A. Pharmacology  288 
In recent years, the existence of fatty acid ethyl esters (FAEEs), non-oxidative 289 
metabolic products of ethanol in blood and various organs with reduced or deficient 290 
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capacity to oxidize ethanol after consumption has been shown. Since these esters 291 
have proven to cause damage to sub cellular structures, they were postulated to be 292 
mediators of organ damage. 293 
Two enzymes catalyse the formation of FAEEs: acyl-coenzyme a-ethanol o-294 
acyltransferase (AEAT) and fatty acid ethyl ester-synthase. Furthermore, pancreatic 295 
lipase, lipoprotein lipase and glutathione transferase were shown to possess FAEE-296 
synthase activity (Tsujita & Okuda, 1992; Bora et al., 1989; 1996). 297 
Fatty acid ethyl esters are formed in the presence of ethanol from free fatty acids, 298 
triglycerides, lipoproteins or phospholipids.  299 
 300 
B. Specific body tissues, time frame and cut-off values 301 
Detectable FAEE levels are found in blood shortly after alcohol consumption and 302 
remain positive for more than 24 hours (Borucki et al., 2005). 303 
Regarding hair analyses, the deposit of lipophilic FAEEs occurs in sebum (Auwärter 304 
et al., 2004). A FAEE cut-off concentration of 0.5 ng/mg for the sum of the four esters 305 
in scalp hair is considered strongly suggestive of chronic excessive alcohol 306 
consumption when measured in the 0 – 3 cm proximal segment. If the proximal 0 - 6 307 
cm segment is used the proposed cut-off concentration is 1.0 ng/mg scalp hair. 308 
The combined use of FAEEs and EtG (see above) can be recommended to increase 309 
the validity of hair analysis (Pragst & Yegles, 2008).  310 
 311 
C. Methodical aspects  312 
Of 15 different FAEEs in hair the sum of four (ethyl stearate, ethyl oleate, ethyl 313 
myristate and ethyl palmitate) are shown to function as a marker in hair analysis 314 
(Pragst & Yegles, 2007). With a cut-off of 0.5 ng/mg, a sensitivity and a specificity of 315 
90 % were reported. A differentiation between abstinent, social and excessive 316 
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drinkers seems possible (Yegles et al., 2004; Gonzalez-Illan, et al., 2011). However, 317 
the complex GC/MS method lacks practicability for routine use. 318 
 319 
D. Limitations:  320 
Regarding hair samples, the analysis of FAEEs alone is not recommended to 321 
determine abstinence from ethanol, but may be used in cases of suspected false 322 
negative HEtG results, utilising a FAEEs cut-off concentration of 0.2 ng/mg for a 0 - 3 323 
cm proximal scalp hair segment or 0.4 ng/mg for a 0 - 6 cm proximal scalp hair 324 
segment. 325 
The concentration of FAEEs in hair can be influenced by cosmetic treatments and 326 
thermal hair straightening tools (Ettlinger et al., 2014).  Regular use of alcohol-327 
containing hair tonic can lead to false positive FAEEs results (Hartwig et al., 2003). 328 
No such false positive results are reported for HEtG (Ferreira et al., 2012).  329 
 330 
 331 
Phosphatidylethanol (PEth)  332 
A. Pharmacology  333 
Phosphatidylethanol (PEth), a phospholipid, is formed in the presence of alcohol via 334 
the action of the enzyme phospholipase-D (PLD) (Alling et al., 1983). The precursors 335 
are naturally existing phosphatidylcholine (PC) homologues. PEth consists of glycerol 336 
which is substituted at positions sn1 and sn2 by fatty acids and is esterified in sn3 337 
position with phosphoethanol (Gustavsson and Alling, 1987; Gnann et al., 2010; 338 
Isaksson et al., 2011; (Kobayashi and Kanfer, 1987). Due to the variations of the fatty 339 
acids, various homologues of PEth can be detected. In 2010, 48 PEth homologues 340 
were described in the blood of a deceased alcohol-dependent individual for the first 341 
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time (Gnann et al., 2010). The PEth homologues 16:0/18:1 und 16:0/18:2 are most 342 
prevalent in human blood (Gnann et al., 2014) and  their combined sum correlates  343 
better with total PEth than PEth 16:0/18:1 or PEth 16:0/18:2 alone (Zheng et al., 344 
2011). 345 
PEth is formed directly after ingestion of alcohol (Gnann et al., 2012), but has a slow 346 
elimination rate with a half-life time of approximately 4 days (Hannuksela et al., 347 
2007). Therefore, PEth is a promising biomarker for the detection of alcohol abuse, 348 
as it can be determined in blood of alcohol abusers even up to 3 weeks after 349 
withdrawal (Viel et al., 2012; Winkler et al., 2013). Using the original high 350 
performance liquid chromatography (HPLC) methods in combination with evaporative 351 
light scattering detection (Varga et al., 1998; (Aradottir and Olsson, 2005)), repeated 352 
consumption of more than 50 g alcohol over 2 - 3 weeks yielded positive results 353 
(Varga et al., 1998), lately even with daily consumption over 40 g (Aradóttir et al., 354 
2004).  355 
Whereas before 2009 the HPLC method was used, later studies employed LC-356 
MS/MS.  357 
 358 
B. Specific body tissues, time frame, cut-off values 359 
With the LC-MS/MS approach single consumption of ethanol up to a blood alcohol 360 
concentration (BAC) of approximately 0.1 g/dL , yielded PEth 16:0/18:1 361 
concentrations up to approx. 120 ng/mL (0.17 μmol/L) (Schröck et al., 2014) in whole 362 
blood. A recent drinking experiment with healthy persons with an alcohol 363 
consumption of 0.1g/dL on 5 consecutive days yielded PEth values up to 237 ng/mL 364 
(0.32 μmol/L) (Gnann et al., 2012). In contrast, in alcohol-dependent patients, the 365 
values were reported to be up to 4200 ng/mL (6 μmol/L) (Helander and Zheng, 2009), 366 
whereas total PEth concentrations of more than 500 ng/mL (0.7 μmol/L) have been 367 
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considered as typical for prolonged alcohol misuse (Isaksson et al., 2011). In 2013, 368 
Swedish laboratories suggested a cut-off for the PEth homologue 16:0/18:1 of 210 369 
ng/mL (0.3 μmol/L ) to differentiate between moderate drinking and alcohol misuse 370 
(Helander and Hansson, 2013).  371 
Various studies found no false positive PEth results (Wurst et al., 2003b, 2004; 372 
Hartmann et al., 2007). A linear relationship between consumed amounts of alcohol 373 
with phosphatidylethanol values has been described (Aradottir et al., 2006; Stewart et 374 
al., 2009; Stewart et al., 2010).  375 
In 144 patients, Aradottir et al. (2004) reported sensitivity of PEth to be 99 %, of CDT, 376 
MCV and GGT to be between 40 – 77 %, as well as a correlation between the 377 
amount consumed and the PEth value. In a receiver operating characteristic (ROC) 378 
curve analysis with consumption status (active drinkers vs abstinent drinkers), as a 379 
state variable and with PEth, MCV and GGT as test variables, an area under the 380 
curve (AUC) of 0.973 for PEth could be found, the sensitivity was 94.5 % and the 381 
specificity 100 % (Hartmann et al., 2007). 382 
These findings were confirmed in subsequent publications (Wurst et al., 2010; 2012; 383 
Stewart et al., 2010; Hahn et al., 2012). Furthermore, liver disease and hypertension 384 
(Stewart et al., 2009; 2014) showed no influence on PEth values. 385 
PEth has been employed in various settings including judging driving ability (Marques 386 
et al, 2010; 2011), forensic psychiatry (Wurst et al., 2003b), monitoring programs 387 
(Skipper et al., 2013), identification of alcohol intake in specific risk groups (Hahn et 388 
al., 2012) and for neonatal screening of prenatal alcohol exposure (Bakhireva et al., 389 
2013, Bakhireva et al., 2014). 390 
 391 
C. Methodical aspects 392 
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Concerning the interpretation of results, it is important to acknowledge that 393 
publications before 2009 used the HPLC method in combination with evaporative 394 
light scattering detection. This method detects the sum of all PEth homologues. In 395 
contrast, new approaches use LC-MS, LC-MS/MS and on-line extraction LC-MS/MS 396 
methods (Schrock et al., 2014). These methods allow the detection and quantification 397 
of single homologues (Gnann et al., 2009), if a reference standard is available. 398 
Furthermore, recent publications suggested LC-HRMS (Liquid Chromatography High 399 
Resolution Mass Spectrometry) method (Nalesso et al., 2011) and a metabolic 400 
approach using LC-MS-IT-TOF (Liquid Chromatography with Quadruple Ion Trap – 401 
Time-of-Flight-Mass Spectrometry) (Loftus et al., 2011). For everyday practical 402 
application, the use of dried blood spots (DBS) may be of significant relevance (Faller 403 
et al., 2013). This method is suggested to provide results similar to whole blood 404 
analysis. Studies of PEth analysis on DBS showed good robustness and the 405 
advantage that neo-formation of PEth in the presence of a positive BAC does not 406 
occur after drying the blood on filter paper (Schrock et al., 2014). Furthermore, 407 
obtaining specimens is simplified since non-medical staff can collect capillary blood, 408 
also storage and transport are simplified, and the risks for HIV and hepatitis C 409 
infections are decreased (Faller et al., 2013). 410 
 411 
D. Limitations 412 
PEth concentrations were shown to be stable in blood samples stored in refrigerators 413 
(2 – 8°C) and when frozen at -80°C. However, decrease in PEth concentrations was 414 
observed during storage at -20°C. When ethanol was present in samples, neo-415 
formation of PEth has been observed (Aradottir et al., 2004).  416 
In-vitro formation of PEth in erythrocytes has been reported after addition of ethanol 417 




II: Practical use in specific patient’s samples and settings:  420 
EtG:    421 
Practical use in specific patient’s samples and settings:  422 
1) Opioid maintenance therapy patients as specific high-risk group:  423 
Many patients in opioid-maintenance therapy suffer from Hepatitis C (HCV) infection. 424 
Alcohol consumption, especially in large amounts, leads to the progression of 425 
cirrhosis (Gitto et al., 2009; Safdar & Schiff, 2004). One study in Australia (Wurst et 426 
al., 2008a) and one in Switzerland (Wurst et al., 2011) showed the usefulness and 427 
necessity of the determination of ethyl glucuronide in patients in opioid-maintenance 428 
therapy. In the former study, 42 % (n = 8 of 19) of all EtG positive patients would 429 
have not reported the alcohol consumption (Wurst et al., 2011). In the latter one, 75 430 
% consumed alcohol according to the hair analysis for EtG, however, two thirds did 431 
not report about it (Wurst et al., 2011). 432 
The use of direct ethanol metabolites in high-risk groups therefore allows more 433 
possibilities for therapeutic interventions, consequently leading to an improvement in 434 
the quality of life. 435 
2) Monitoring and rehabilitation programs:  436 
a) One example for using ethyl glucuronide successfully in monitoring programs are 437 
the Physician Health Programmes in the USA which provide a non-disciplinary 438 
therapeutic program for physicians with potentially impairing health conditions such 439 
as substance related disorders. Participating in the monitoring program, physicians 440 
with substance related disorders are allowed to keep on working whereas a regularly 441 
proof of abstinence has to be shown. Measuring EtG in urine, Skipper and colleagues 442 
(Skipper et al., 2004) showed that of 100 randomly collected samples, no sample 443 
was positive for alcohol using standard testing; however, seven were positive for EtG 444 
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(0.5 – 196 mg/L), suggesting recent alcohol use. EtG testing can provide additional 445 
information and consequently, may lead to further treatment and improvement for the 446 
patient (Skipper et al., 2004, 2013).  447 
b) The usefulness of EtG measurement during inpatient treatment in a rehabilitation 448 
program has been shown in two studies (Junghanns et al., 2009; Wetterling et al. 449 
2014). The results suggest that there is a considerable number of inpatients 450 
consuming alcohol during weekend leaves which is not detected by self-report or 451 
breath alcohol analyses. Of patients who lapsed during weekend leaves, a high 452 
proportion did not complete treatment. Furthermore, lapsers completing treatment did 453 
have a significantly reduced chance to reach abstinence during follow-ups.  454 
3) Pharmacotherapy efficacy studies: 455 
As an objective outcome parameter, EtG testing has shown to be useful in 456 
pharmaco-therapeutical studies (Dahl et al., 2011b; Mitchell et al., 2012, Jatlow et al., 457 
2014). 458 
4) Hangover state: 459 
A potential role of EtG in the context of neurocognitive impairment following heavy 460 
drinking, usually referred to as hangover state, has previously been suggested 461 
(Wurst et al., 2003a; Stephens et al., 2014). Results of a recent study (Hoiseth et al., 462 
2015) seem to consolidate this idea.  463 
5) In addition, EtG can also be detected in specimens of dried blood, which is of 464 
relevance for forensic investigations (Kaufmann & Alt, 2008; Winkler et al., 2011; 465 
Hernandez Redondo et al., 2013) 466 
6) Liver transplantation: 467 
Alcohol-related liver disease accounts for up to 30 % of liver transplants (Burroughs 468 
et al., 2006). Post-operatively, 20 – 25 % of the patients’ lapse or relapse to alcohol 469 
intake (Kelly et al., 2006; DiMartini et al., 2006). In 18 patients with ALD (alcohol liver 470 
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disease) Erim et al. (2007) found no self-report on alcohol consumption. One out of 471 
127 tests for breath alcohol was positive, whereas 24 of 49 urine samples were 472 
positive for EtG. Webzell et al. (2011), who found self-reported alcohol consumption 473 
in 3 % in contrast to 20 % positive urine EtG and EtS tests, reported comparable 474 
results. Recently, Piano et al. (2014) found that the combination of AUDIT-C and EtG 475 
in urine improves the detection of alcohol consumption in liver transplant candidates 476 
and liver transplant recipients and showed higher accuracy in detecting alcohol 477 
consumption than the combination of AUDIT–C and CDT. 478 
EtG in hair (HEtG) allows retrospective determination of alcohol consumption for up 479 
to 6 months that is the abstention period often required by transplant programs prior 480 
to listing patients. Several studies have evaluated HEtG concentrations in liver 481 
transplant patients, proposing it to be a highly specific and useful tool for the 482 
monitoring of alcohol use before, and after liver transplantation (Sterneck et al., 2013; 483 
Hilke et al., 2014) and superior to traditional markers. Further substantial advantages 484 
compared to routine methods of alcohol detection in urine or blood are, that obtaining 485 
hair samples is non-invasive and storage of the samples is easy. Despite their 486 
excellent profile, it is not advisable to use the results of hair testing for alcohol 487 
markers in isolation and conclusions always should be corroborated by a clinical 488 
assessment and interpretation. 489 
On this background, Allen et al (2013) conclude in a recent review regarding liver 490 
transplantation that ethyl glucuronide tests in urine and hair are complementary to 491 
self-reports and questionnaires, yielding valuable information on alcohol 492 
consumption, which is relevant in diagnosis and therapy. 493 
7) Alcohol metabolites and fetal alcohol syndrome (FAS)  494 
Alcohol consumption during pregnancy may lead to fetal alcohol syndrome (FAS) and 495 
the fetal alcohol spectrum disorder (FASD), characterized by congenital 496 
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abnormalities, cognitive dysfunction and developmental problems. Estimations report 497 
that the prevalence of FAS and FASD is 0.2 to 1 per 100 life-births in industrialized 498 
countries (Sampson et al., 1997; Stade et al., 2009).  499 
A recent study reported that 50% of Italian and 40% of Spanish women occasionally 500 
consumed alcohol during pregnancy (Vagnarelli et al., 2011).  501 
Alcohol intake during pregnancy can be investigated in  502 
a) maternal (including hair, blood, urine) and  503 
b) fetal specimen (meconium) (Joya et al., 2012).  504 
To date there is only one study (Wurst et al., 2008c) employing EtG in urine and hair 505 
in pregnant women assessing alcohol intake compared with self-reports: Women at 506 
the end of the second trimester were included. The AUDIT identified 25.2 % women 507 
consuming any alcohol during pregnancy. None of the participants scored above the 508 
gender-specific AUDIT score higher than the cut-off value of 4 points. However, 509 
according to the hair analysis, 12 women drank 20 - 40 g ethanol per day, and 4 had 510 
an intake over 60 g/day (Wurst et al., 2008c). The results of the study also indicate 511 
that the combination of AUDIT and biomarkers identified more alcohol use than the 512 
questionnaire alone.  513 
These results support the application of direct alcohol metabolites in pregnant women 514 
since increases of %CDT (percent of carbohydrate deficient transferrin vs. total 515 
transferrin) and its isoforms were reported for this specific population (Bianchi et al., 516 
2011; Kenan et al., 2011).  517 
Studies on fetal specimen include current measures of meconium. These measures 518 
are a cumulative indicator of alcohol consumption, since it is formed between the 12th 519 
and 16th week of pregnancy. While the first studies investigated FAEEs 520 
concentrations, recent research focused on EtG and EtS. The largest study 521 
investigated meconium of 607 newborns. 7.9 % of specimens indicated maternal 522 
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alcohol intake during pregnancy. Low maternal education level and age were 523 
associated with biomarker values above the cut-off (Pichini et al., 2012). In contrast, 524 
Goecke et al., (2014) found in 557 births no correlation between socioeconomic or 525 
psychological characteristics and those women positively tested for alcohol use via 526 
meconium. Regarding FAEEs detection, the specimen has to be investigated 527 
promptly. One study reported that negative meconium values in 19 babies turned 528 
positive within 59 hours. Following the authors’ in-vivo- and in-vitro studies, this 529 
change may be caused by contamination through nutritional components, postnatal 530 
feces and ethanol-producing germs (Zelner et al., 2012). This may also be the cause 531 
for 82.8 % EtG and 22.2 % FAEEs positive values in meconium, reported by another 532 
study (Morini et al., 2010b). Results of a recent study suggest that maternal ethanol 533 
intake was better represented by meconium EtG ≥30 ng/g than by currently used 534 
FAEE cutoffs (Himes et al., 2015). 535 
Also the usefulness of PEth measurement in whole blood during pregnancy was 536 
described (Stewart et al., 2010; Kwak et al., 2014). In addition, capillary blood 537 
sampling for PEth analysis on DBS has been applied for neonatal screening of 538 
prenatal alcohol exposure with promising results (Bakhireva et al., 2013, Bakhireva et 539 
al., 2014) 2014) 540 
 541 
Summary and Discussion:  542 
In summary, ethanol metabolites reflect the spectrum between short-term intake of 543 
small amounts and long-term use of large amounts of alcohol.  Cut-off values and 544 
influencing factors are summarized in tables 1 and 2. Appropriate methods of 545 
analysis and pre-analytics are crucial for a valid and reliable detection of alcohol 546 
biomarkers. For EtG, the most frequently used marker, the most recommended 547 
methods for detection are chromatographic approaches, which are considered as 548 
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standard methods especially in forensic cases. A commercial test-kit is available and 549 
contributed to wide distribution of the test. Laboratory values always require critical 550 
clinical reappraisal, especially since EtG is detectable in urine using LC-MS/MS even 551 
after an ingestion of low amounts of alcohol (1 g), which also occurs in some food, 552 
drugs and disinfectants. Individuals with the motivation to or obligation for abstinence 553 
have to be informed about these “hidden contents” to avoid unintentional intake of 554 
alcohol.  For forensic purposes, the current cut-off value of 0.1 mg/L should be 555 
adapted to exclude cases of unintentional alcohol use. With respect to differences in 556 
formation and degradation, EtG and EtS should be analyzed together, if possible. In 557 
the absence of known influencing factors, EtG in hair can be recommended as a 558 
marker for alcohol intake over the last 3 months. Furthermore, guidelines for 559 
interpretations of values are available from the Society of Hair Testing (SOHT, 2014). 560 
While positive urine values of EtG and EtS can be in accord with 561 
innocent/unintentional alcohol intake, positive values of PEth are related to previous 562 
intoxications of 0.05 g/dL and more.  563 
Therefore, PEth is currently used to differentiate between moderate drinking and 564 
excessive alcohol use, based on thresholds derived from clinical investigations. A 565 
suggested threshold of 0.3 micromole/Liter (210 ng/mL) PEth (Helander and 566 
Hansson, 2013) seems promising, however needs further evaluation and verification 567 
by studies with larger numbers of social drinkers. Furthermore, inter-individual 568 
differences should be investigated, which might depend on differences in 569 
phospholipase-D activities. New developments achieved by more sensitive analysis 570 
methods and drinking experiments show the potential of PEth in abstinence 571 
monitoring (Schrock et al., 2014). Due to stability issues the use of „dried blood 572 
spots“(DBS) in PEth analysis is promising: a) In vitro formation of PEth in alcohol-573 
containing blood does not occur after drying blood on filter paper, b) it may facilitate 574 
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blood sampling (capillary blood instead of venous blood), storage and shipping of 575 
samples. 576 
As biomarkers with high sensitivity and specificity covering complimentary time 577 
windows from hours to several months, depending on the biological material used for 578 
analysis and the choice of the respective biomarker, ethanol metabolites can be 579 
applied in different settings such as screening, prevention, diagnosis and therapy of 580 
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Table 1: Suggested cut-off values for different ethanol metabolites   
Biomarkers  Amount of alcohol 
consumption 
Cut-off Reference  
EtG in hair  Abstinence and low intake  
(< 10 g/d)  
< 7 pg/mg  SOHT , 2014  
Social consumption (20 - 40 
g/d) 
7 – 30 pg/mg 
Excessive drinking (>60 
g/d) 
> 30 pg/mg 
FAEEs in 
hair 
Repeated alcohol  intake ≥ 200 pg/mg  SOHT, 2014   
Excessive intake  ≥ 500 pg/mg  
EtG in urine  Total abstinence 0.1 mg/L Thierauf et al., 
2009; 
SAMHSA, 2012 
 - unintentional  intake 
- recent alcohol use  
- previous heavy alcohol 
intake 
0.1 mg/L– 0.5mg/L 
 unintentional  intake 
unlikely, but possible, active 
alcohol intake probable  
0.5-1 mg/L 
EtS in urine Total abstinence  0.05 mg/L Albermann et 
al., 2012b 
PEth in blood Abstinence and low intake 150 ng/mL (0.22 µmol/L) 
total PEth with HPLC 
 
 
20 ng/mL (0.03 μmol/L) 
PEth 16:0/18:1 (LC-MS/MS) 
 
 
35 ng/mL (0.05 μmol/L) 
PEth 16:0/18:1 (LC-MS/MS) 
Varga et al., 
1998; Aradottir 
et al., 2004 
 
Gnann et al., 
2009 ; Schröck 
et al., 2014 
 
Helander et al., 
2013 
 Drinking experiments: 
a) Single consumption 





120 ng/mL (0.17 μmol/L) 










b) Repeated drinking 
(5 consecutive days, 
>40 g each) 
 
240 ng/mL (0.34 μmol/L) 
PEth 16:0/18:1 (LC-MS/MS) 
 
 
Gnann et al., 
2012 
 
 Excessive drinking  
(>40 g/d, more than 2 
weeks) 
500 ng/mL (0.7 μmol/L) 
total PEth (HPLC) 
 
800 ng/mL (1.14 μmol/L) 
PEth 16:0/18:1 (LC-MS/MS) 
 
210 ng/mL (0.3 μmol/L) 
PEth 16:0/18:1 (LC-MS/MS) 
 
Isaksson et al., 
2011 
 
Gnann H., 2011 
 
 
Helander et al., 
2013 
EtG: Ethyl glucuronide, FAEEs: Fatty acid ethyl esters in hair, EtS: Ethyl sulfate, PEth: 
Phosphatidylethanol; (modified according to Thon et al., 2013) LC-MS/MS: liquid 
chromatography – tandem mass spectrometry 
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 Table 2a: Factors without known influence on ethanol metabolite levels 
Direct bio-
markers  
Potential influencing factor Reference  
EtG in urine No influence of E. coli on EtG levels in 
urine, when dried urine spots are used  
Hernandez Redondo et 
al., 2012 
Grade of liver disease, smoking, BMI, 
body water content 
Wurst et al., 2004a;  
 
EtS in urine No influence of E. coli on EtS levels in 
urine, when dried urine spots are used  
Hernandez Redondo et 
al., 2012 
PEth Liver disease  Stewart et al., 2009 
Hypertension 
Storage of ethanol blood samples 
 Refrigerator temperature, -80°C 
Aradottir et  al., 2004 
 Gender Wurst et al., 2010 
EtG in hair  Hairsprays with ethanol, hair colour, 
melanin content, age, gender, BMI 
Ferreira et al., 2012; 
Kharbouche et al., 
2010; Kulaga et al., 
2009; Appenzeller et 
al., 2007 
Crunelle et al., 2014 
 
EtG: Ethyl glucuronide, FAEE: Fatty acid ethyl esters, EtS: Ethyl sulfate, PEth: 
Phosphatidylethanol, BMI: body mass index, RT: room ambient temperature, E. coli: 
Escherichia coli, C. sordelli: Clostridium sordelli (modified according to Thon et al., 2013) 
  




Table 2b: Factors with known influence on ethanol metabolite levels 
Direct bio-
markers  
Potential influencing factor Type of 
influence  
Reference  
EtG in urine E. coli, C. sordelli Decrease Helander & Dahl, 2005; 
Baranowksi et al., 2008 
Reduced kidney function Longer 
detection  
Wurst et al., 2004a; 
Hoiseth et al., 2012 ; 
Stewart et al., 2013 
Chloral hydrate  False 
positives 
Arndt et al., 2009 
 Propyl and butyl alcohol False 
positives 
in  DRI 
EtG Assay 
Arndt et al, 2014b 
EtS in urine Reduced kidney function Longer 
detection 
Hoiseth et al., 2012 
Closed Bottle test (OECD 301 D)  







Halter et al., 2009 
FAEEs in hair  Aggressive alkaline hairsprays False 
negative  
Hartwig et al., 2003 
Hairsprays containing ethanol False 
positives 
PEth Ethanol containing blood samples, 
Storage of ethanol blood samples at RT 
and -20°C 
Increase  Aradottir et al 2004 
EtG in hair Hairspray with EtG  Increase  Sporkert et al. 2012 
Reduced kidney function  Increase  Hoiseth et al. 2013 
Bleaching, hair styling products False 
negative  
Yegles et al., 2004; 
Morini et al., 2010 
Kerekes et al., 2013 
 Commercial hair tonics 
containing EtG  
Potentially 
false 




 Thermal hair straightening Decrease Ettlinger et al, 2014 
EtG: Ethyl glucuronide, FAEE: Fatty acid ethyl esters, EtS: Ethyl sulfate, PEth: 
Phosphatidylethanol, BMI: body mass index, RT: room ambient temperature, E. coli: 
Escherichia coli, C. sordelli: Clostridium sordelli (modified according to Thon et al., 2013) 
 
